166 related articles for article (PubMed ID: 25156682)
1. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases free survival differs between breast cancer subtypes.
Berghoff A; Bago-Horvath Z; De Vries C; Dubsky P; Pluschnig U; Rudas M; Rottenfusser A; Knauer M; Eiter H; Fitzal F; Dieckmann K; Mader RM; Gnant M; Zielinski CC; Steger GG; Preusser M; Bartsch R
Br J Cancer; 2012 Jan; 106(3):440-6. PubMed ID: 22233926
[TBL] [Abstract][Full Text] [Related]
3. Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.
Kawai M; Malone KE; Tang MT; Li CI
Cancer; 2014 May; 120(10):1548-56. PubMed ID: 24500704
[TBL] [Abstract][Full Text] [Related]
4. Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis.
Depner JF; Berg T; Ejlertsen B; Andreasen LW; Møller S; Maraldo MV
Acta Oncol; 2023 Nov; 62(11):1502-1510. PubMed ID: 37750329
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review.
Dawood S; Gonzalez-Angulo AM; Albarracin C; Yu TK; Hortobagyi GN; Buchholz TA; Woodward WA
Cancer; 2010 Jul; 116(13):3084-92. PubMed ID: 20564633
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade.
Avila J; Leone J; Vallejo CT; Lin NU; Leone JP
Breast Cancer Res Treat; 2024 Jun; 205(3):579-587. PubMed ID: 38453783
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Predictive Immunohistochemical Marker Expression of Primary Breast Cancer and Paired Distant Metastasis using Surgical Material: A Practice-Based Study.
Kulka J; Székely B; Lukács LV; Kiss O; Tőkés AM; Vincze E; Turányi E; Fillinger J; Hanzély Z; Arató G; Szendrői M; Győrffy B; Szász AM
J Histochem Cytochem; 2016 Apr; 64(4):256-67. PubMed ID: 27029768
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Spinal Metastases Surgery Risk Stratification Tools in Breast Cancer by Molecular Subtype.
Duvall JB; Massaad E; Siraj L; Kiapour A; Connolly I; Hadzipasic M; Elsamadicy AA; Williamson T; Shankar GM; Schoenfeld AJ; Fourman MS; Shin JH
Neurosurgery; 2023 Jan; 92(1):83-91. PubMed ID: 36305664
[TBL] [Abstract][Full Text] [Related]
9. Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer.
Wang HF; Chen Y; Cao B; Pei J
Med Sci Monit; 2024 Mar; 30():e943049. PubMed ID: 38553816
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients.
Herrera AC; Panis C; Victorino VJ; Campos FC; Colado-Simão AN; Cecchini AL; Cecchini R
Cancer Immunol Immunother; 2012 Nov; 61(11):2193-201. PubMed ID: 22618884
[TBL] [Abstract][Full Text] [Related]
11. Management of Brain and Leptomeningeal Metastases from Breast Cancer.
Pellerino A; Internò V; Mo F; Franchino F; Soffietti R; Rudà R
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198331
[TBL] [Abstract][Full Text] [Related]
12. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto W; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; Yu J; Chiang V; Nakano T; Aoyama H; Mehta MP
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):334-343. PubMed ID: 32084525
[TBL] [Abstract][Full Text] [Related]
13. The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer.
Amansyah F; Prihantono P; Hamid F; Syamsu SA; Pieter J; Faruk M
Breast Dis; 2024; 43(1):71-78. PubMed ID: 38669518
[TBL] [Abstract][Full Text] [Related]
14. A case report and literature review on a rare subtype of triple-negative breast cancer in children.
Shi L; Zhang Y; Wu J; Li J; Zhu J; Xu Y; Li N; Li Q; Zhang W
BMC Pediatr; 2023 Sep; 23(1):494. PubMed ID: 37773118
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Prognosis: A Study on Mortality Indicators.
Moushaly RA; Păduraru DN; Andronic O; Nechita S; Bolocan A; Palcău C; Muşat F; Ion D
Chirurgia (Bucur); 2023 Oct; 118(5):534-542. PubMed ID: 37965837
[No Abstract] [Full Text] [Related]
16. Breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer.
Huang ML; Lane DL; Bomar H; Kuerer H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38627044
[TBL] [Abstract][Full Text] [Related]
17. Triple Negative Breast Cancer and Brain Metastases.
Bansal R; Van Swearingen AED; Anders CK
Clin Breast Cancer; 2023 Dec; 23(8):825-831. PubMed ID: 37586926
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular mechanisms underlying brain metastasis of breast cancer.
Hosonaga M; Saya H; Arima Y
Cancer Metastasis Rev; 2020 Sep; 39(3):711-720. PubMed ID: 32399646
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.
Zhang H; Ahearn TU; Lecarpentier J; Barnes D; Beesley J; Qi G; Jiang X; O'Mara TA; Zhao N; Bolla MK; Dunning AM; Dennis J; Wang Q; Ful ZA; Aittomäki K; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Arun BK; Auer PL; Azzollini J; Barrowdale D; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bialkowska K; Blanco A; Blomqvist C; Bogdanova NV; Bojesen SE; Bonanni B; Bondavalli D; Borg A; Brauch H; Brenner H; Briceno I; Broeks A; Brucker SY; Brüning T; Burwinkel B; Buys SS; Byers H; Caldés T; Caligo MA; Calvello M; Campa D; Castelao JE; Chang-Claude J; Chanock SJ; Christiaens M; Christiansen H; Chung WK; Claes KBM; Clarke CL; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Diez O; Domchek SM; Dörk T; Dwek M; Eccles DM; Ekici AB; Evans DG; Fasching PA; Figueroa J; Foretova L; Fostira F; Friedman E; Frost D; Gago-Dominguez M; Gapstur SM; Garber J; García-Sáenz JA; Gaudet MM; Gayther SA; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Gronwald J; Guénel P; Häberle L; Hahnen E; Haiman CA; Hake CR; Hall P; Hamann U; Harkness EF; Heemskerk-Gerritsen BAM; Hillemanns P; Hogervorst FBL; Holleczek B; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Howell A; Huebner H; Hulick PJ; Imyanitov EN; ; ; Isaacs C; Izatt L; Jager A; Jakimovska M; Jakubowska A; James P; Janavicius R; Janni W; John EM; Jones ME; Jung A; Kaaks R; Kapoor PM; Karlan BY; Keeman R; Khan S; Khusnutdinova E; Kitahara CM; Ko YD; Konstantopoulou I; Koppert LB; Koutros S; Kristensen VN; Laenkholm AV; Lambrechts D; Larsson SC; Laurent-Puig P; Lazaro C; Lazarova E; Lejbkowicz F; Leslie G; Lesueur F; Lindblom A; Lissowska J; Lo WY; Loud JT; Lubinski J; Lukomska A; MacInnis RJ; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Martinez ME; Matricardi L; McGuffog L; McLean C; Mebirouk N; Meindl A; Menon U; Miller A; Mingazheva E; Montagna M; Mulligan AM; Mulot C; Muranen TA; Nathanson KL; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Nielsen FC; Nikitina-Zake L; Nodora J; Offit K; Olah E; Olopade OI; Olsson H; Orr N; Papi L; Papp J; Park-Simon TW; Parsons MT; Peissel B; Peixoto A; Peshkin B; Peterlongo P; Peto J; Phillips KA; Piedmonte M; Plaseska-Karanfilska D; Prajzendanc K; Prentice R; Prokofyeva D; Rack B; Radice P; Ramus SJ; Rantala J; Rashid MU; Rennert G; Rennert HS; Risch HA; Romero A; Rookus MA; Rübner M; Rüdiger T; Saloustros E; Sampson S; Sandler DP; Sawyer EJ; Scheuner MT; Schmutzler RK; Schneeweiss A; Schoemaker MJ; Schöttker B; Schürmann P; Senter L; Sharma P; Sherman ME; Shu XO; Singer CF; Smichkoska S; Soucy P; Southey MC; Spinelli JJ; Stone J; Stoppa-Lyonnet D; ; ; Swerdlow AJ; Szabo CI; Tamimi RM; Tapper WJ; Taylor JA; Teixeira MR; Terry M; Thomassen M; Thull DL; Tischkowitz M; Toland AE; Tollenaar RAEM; Tomlinson I; Torres D; Troester MA; Truong T; Tung N; Untch M; Vachon CM; van den Ouweland AMW; van der Kolk LE; van Veen EM; vanRensburg EJ; Vega A; Wappenschmidt B; Weinberg CR; Weitzel JN; Wildiers H; Winqvist R; Wolk A; Yang XR; Yannoukakos D; Zheng W; Zorn KK; Milne RL; Kraft P; Simard J; Pharoah PDP; Michailidou K; Antoniou AC; Schmidt MK; Chenevix-Trench G; Easton DF; Chatterjee N; García-Closas M
Nat Genet; 2020 Jun; 52(6):572-581. PubMed ID: 32424353
[TBL] [Abstract][Full Text] [Related]
20. Update on the Use of Molecular Subtyping in Breast Cancer.
Lawton TJ
Adv Anat Pathol; 2023 Nov; 30(6):368-373. PubMed ID: 37746905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
